Late‑breaking EULAR results highlight sustained responses through week 52
Commission authorisation expands access to passive measles prophylaxis for vulnerable patients
Updated Date: Wed, 27 May 2026 00:00:00 EDT
Updated Date: Wed, 27 May 2026 00:00:00 EDT
Early clinical activity supports expansion into broader IgA‑mediated conditions
Adding durvalumab to chemoradiation helps people avoid having their bladder removed
Scientists have developed an experimental diabetes and obesity pill that works in a completely different way from drugs […]
Updated Date: Tue, 26 May 2026 00:00:00 EDT
Updated Date: Mon, 25 May 2026 00:00:00 EDT
New collaboration aims to break barriers in brain‑targeted drug discovery